|
CN111620834A
|
|
Preparation method and intermediate of benzodiazepine compound
|
|
CN110672737A
|
|
Method for identifying American cockroaches
|
|
WO2020034946A1
|
|
Method for preparing cyclohexane derivative
|
|
WO2020042903A1
|
|
Salt of cyclohexane derivative
|
|
CN111943880A
|
|
Buvalracetam crystal and preparation method and application thereof
|
|
CN111714467A
|
|
Live bacillus enteric-coated capsule and preparation method thereof
|
|
CN111393425A
|
|
Preparation method of 6-fluoro-3-piperidine-4-yl-1, 2-benzisoxazole hydrochloride
|
|
CN111393398A
|
|
Preparation method of tasimelteon
|
|
CN111362893A
|
|
Preparation method of tasimelteon intermediate
|
|
CN111349007A
|
|
Preparation method of (R) -4-propyl-dihydrofuran-2-ketone and preparation intermediate thereof
|
|
CN111330018A
|
|
Vortioxetine-cyclodextrin inclusion compound, preparation method and pharmaceutical composition thereof
|
|
CN111320568A
|
|
Novel crystal form of pimavanserin and preparation method thereof
|
|
CN111269211A
|
|
Preparation method of benzothiophene derivative
|
|
CN111269199A
|
|
Preparation method of cariprazine
|
|
CN111233866A
|
|
Process for the preparation of tofacitinib or a salt thereof
|
|
CN111196771A
|
|
Compound, preparation method thereof and application thereof in preparation of brivaracetam
|
|
CN111187248A
|
|
Preparation method of cyclohexane derivative maleate crystal form
|
|
CN111170920A
|
|
Method for removing genotoxicity warning intermediate from brivaracetam
|
|
CN111110647A
|
|
Pharmaceutical composition containing colesevelam hydrochloride and preparation method thereof
|
|
CN111100111A
|
|
Method for preparing benzothiophene derivative
|
